JP2024547111A5 - - Google Patents

Info

Publication number
JP2024547111A5
JP2024547111A5 JP2024537958A JP2024537958A JP2024547111A5 JP 2024547111 A5 JP2024547111 A5 JP 2024547111A5 JP 2024537958 A JP2024537958 A JP 2024537958A JP 2024537958 A JP2024537958 A JP 2024537958A JP 2024547111 A5 JP2024547111 A5 JP 2024547111A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
antibody
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547111A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/141572 external-priority patent/WO2023116911A1/zh
Publication of JP2024547111A publication Critical patent/JP2024547111A/ja
Publication of JP2024547111A5 publication Critical patent/JP2024547111A5/ja
Pending legal-status Critical Current

Links

JP2024537958A 2021-12-24 2022-12-23 抗FRα抗体及びその抗体薬物コンジュゲート並びに使用 Pending JP2024547111A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202111602429 2021-12-24
CN202111602429.4 2021-12-24
CN202211408028.X 2022-11-10
CN202211408028 2022-11-10
PCT/CN2022/141572 WO2023116911A1 (zh) 2021-12-24 2022-12-23 抗FRα抗体及其抗体药物偶联物和用途

Publications (2)

Publication Number Publication Date
JP2024547111A JP2024547111A (ja) 2024-12-26
JP2024547111A5 true JP2024547111A5 (cg-RX-API-DMAC7.html) 2025-11-28

Family

ID=86879676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537958A Pending JP2024547111A (ja) 2021-12-24 2022-12-23 抗FRα抗体及びその抗体薬物コンジュゲート並びに使用

Country Status (5)

Country Link
US (1) US20250059274A1 (cg-RX-API-DMAC7.html)
EP (1) EP4455164A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024547111A (cg-RX-API-DMAC7.html)
CN (1) CN116333135A (cg-RX-API-DMAC7.html)
WO (1) WO2023116911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024263367A1 (en) 2023-04-27 2025-11-13 CSPC Megalith Biopharmaceutical Co., Ltd. Antibody-drug conjugate
EP4735047A1 (en) * 2023-06-28 2026-05-06 Université de Tours Pegylated linkers and uses thereof
CN121772942A (zh) * 2023-08-11 2026-03-31 百奥泰生物制药股份有限公司 抗FRα抗体药物偶联物在治疗疾病中的应用
WO2025140416A1 (zh) * 2023-12-28 2025-07-03 上海宏成药业有限公司 抗folr1特异性抗体的发明及应用
WO2025190255A1 (zh) * 2024-03-12 2025-09-18 百奥泰生物制药股份有限公司 治疗宫颈癌、胸腺肿瘤或激素受体阳性和her2阴性乳腺癌的方法
CN120919340A (zh) * 2024-05-09 2025-11-11 百奥泰生物制药股份有限公司 抗FRα抗体药物偶联物和PD-1拮抗剂在治疗肿瘤中的应用
WO2026002191A1 (zh) * 2024-06-29 2026-01-02 百奥泰生物制药股份有限公司 新型药物偶联物及其用途
CN118791615B (zh) * 2024-07-22 2025-03-21 上海生物制品研究所有限责任公司 抗FRα抗体或抗原结合片段、抗体偶联药物及其应用
FR3164899A1 (fr) * 2024-07-24 2026-01-30 Skymab Biotherapeutics Conjugue anticorps-medicament et ses utilisations
CN121606577A (zh) * 2024-08-27 2026-03-06 百奥泰生物制药股份有限公司 抗FRα抗体药物偶联物和VEGF拮抗剂在治疗肿瘤中的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR50E (fr) 1901-07-17 1902-10-13 Roche Un nouveau procédé de dégrisage du velours
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4694778A (en) 1984-05-04 1987-09-22 Anicon, Inc. Chemical vapor deposition wafer boat
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
US5258498A (en) 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5777085A (en) 1991-12-20 1998-07-07 Protein Design Labs, Inc. Humanized antibodies reactive with GPIIB/IIIA
WO1993016043A1 (en) 1992-02-18 1993-08-19 Otsuka Kagaku Kabushiki Kaisha β-LACTAM COMPOUND AND CEPHEM COMPOUND, AND PRODUCTION THEREOF
US5714350A (en) 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
EP0983303B1 (en) 1997-05-21 2006-03-08 Biovation Limited Method for the production of non-immunogenic proteins
AU776910B2 (en) 1998-12-08 2004-09-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Modifying protein immunogenicity
WO2003016466A2 (en) 2001-08-17 2003-02-27 Eli Lilly And Company ANTI-Aβ ANTIBODIES
JP4968615B2 (ja) 2004-12-16 2012-07-04 日本電気株式会社 二次電池用電解液及び二次電池
SG11201500938XA (en) 2012-08-31 2015-04-29 Immunogen Inc Diagnostic assays and kits for detection of folate receptor 1
US10195288B2 (en) * 2012-10-11 2019-02-05 Daiichi Sankyo Company, Limited Antibody-drug conjugate
EP2997044A4 (en) * 2013-05-14 2017-03-22 ImmunoGen, Inc. Anti-folr1 immunoconjugate dosing regimens
NZ717140A (en) 2013-08-30 2022-05-27 Immunogen Inc Antibodies and assays for detection of folate receptor 1
JP6463744B2 (ja) * 2013-10-08 2019-02-06 イミュノジェン, インコーポレイテッド 抗folr1免疫抱合体投薬レジメン
US20210093733A1 (en) * 2016-11-21 2021-04-01 Obi Pharma, Inc. Conjugated biological molecules, pharmaceutical compositions and methods
WO2019243825A1 (en) * 2018-06-21 2019-12-26 Curadev Pharma Limited Small molecule modulators of human sting, conjugates and therapeutic applications
JP2021529557A (ja) * 2018-06-29 2021-11-04 ジェンサン バイオファーマ、 インコーポレイテッドGensun Biopharma, Inc. 抗腫瘍免疫チェックポイント調節因子アンタゴニスト
EP4349371A4 (en) * 2021-06-02 2025-06-25 Bio-Thera Solutions, Ltd. DRUG CONJUGATE AND USE THEREOF

Similar Documents

Publication Publication Date Title
AU2018267660B2 (en) Compounds and methods for the treatment of TROP2 positive diseases
JP2024520674A5 (cg-RX-API-DMAC7.html)
JP2024520674A (ja) 薬物コンジュゲート及びその使用
JP2018525354A5 (cg-RX-API-DMAC7.html)
SI2582728T1 (en) Human Antibodies Conjugates against a Tissue Factor
WO2023198079A1 (zh) 治疗her2阳性实体瘤的方法
WO2024235132A9 (zh) 具有生物活性的化合物及其制备方法和用途
WO2024235128A1 (zh) 抗体药物偶联物及其制备方法和用途
EP4566632A1 (en) Msln antibody-drug conjugate
JP2025148380A5 (cg-RX-API-DMAC7.html)
WO2024235136A9 (zh) 杂环类化合物及其制备方法和用途
WO2025011419A1 (zh) 一种连接子-药物分子及抗体药物偶联物、其制备方法和应用
CN119421724A (zh) 治疗实体瘤的方法
JP2023036874A (ja) イムノコンジュゲートにおけるメチオニン酸化を防止する方法
WO2024235134A1 (zh) 具有靶向作用的偶联物及其制备方法和用途
WO2025167743A1 (zh) 抗体药物偶联物及其制备方法和用途
WO2024235130A9 (zh) 多环化合物及其制备方法和用途
WO2024235133A9 (zh) 多环类药物偶联物及其制备方法和用途
KR20250112249A (ko) 융합된 고리 화합물, 이의 접합체 및 이의 용도
CN119053607B (zh) 喜树碱类化合物及其偶联物、其制备方法和用途
CN119300868B (zh) 喜树碱类化合物及其偶联物、其制备方法和用途
WO2025167742A1 (zh) 抗体药物偶联物及其制备方法和用途
WO2025045015A1 (zh) 抗体-药物缀合物及其制备方法和用途
WO2026067713A1 (zh) 抗体药物偶联物,及其制备方法和用途
RU2849612C2 (ru) Конъюгат антитело-препарат и его применение